| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |